London, UK 4/20/17—Technical products firm Diploma has acquired Abacus for £13.6 million ($19.4 million at £0.70 = $1), including net debt, and deferred consideration of up to £2.1 million ($3.0 million). With 44 employees at locations in Australia and New Zealand, Abacus supplies clinical diagnostics instruments and consumables to the pathology and life sciences markets. For the year ending June 30, 2016, Abacus generated revenues of £13.6 million ($20 million). Abacus will join Diploma’s Life Sciences business.

For the life sciences, Abacus is a distributor for a number of companies, including Baker Company, Bio-Rad and Merck Millipore. Part of Diploma’s Life Sciences division, Diploma Healthcare distributes specialty surgical and diagnostic products for health care and clinical laboratory customers.